China Approves APT Medical Unit's Atrial Fibrillation Treatment Device

MT NewswiresDec 19 13:15

APT Medical Inc. (688617.SH): The disposable magnetic positioning pressure monitoring pulsed electric field ablation catheter has obtained the medical instruments registration certificate.

Gelonghui reported on December 18th that APT Medical Inc. (688617.SH) announced that on December 17, 2024, its wholly-owned subsidiary Hunan APT Medical Instruments Co., Ltd. obtained a medical instruments registration certificate for a product named: disposable magnetic field positioning pressure monitoring pulse electric field ablation catheter. This product is used in medical Institutions and is to be used in conjunction with Shanghai Hongtong Industrial Co., Ltd.'s heart pulse electric field ablation device (model: PFG-micro1, software release version V1). It needs to be used together with the disposable heart pulse electric field ablation catheter produced by the company for the treatment of drug-resistant and recurrent diseases.

Gelonghui FinanceDec 18 15:54

Express News | Guosheng Securities: APT Medical Inc.'s PFA products have good safety and effectiveness, maintaining a "Buy" rating.

BreakingsDec 17 15:02

Research Reports Mining丨Guosheng Securities: APT Medical Inc.'s PFA products have good safety and effectiveness, maintaining a "Buy" rating.

Guosheng Securities' Research Reports pointed out that APT Medical Inc. (688617.SH) PFA product integrates three major functional characteristics, possessing good safety and efficacy. The company's PFA innovative product is the first in the Global to combine "pressure sensing / contact indication" + "magnetic定位三维标测" + "pulse ablation" into one ablation system, featuring unique technical advantages. The approval of the company's PFA products has enriched the product layout in the electrophysiology field, and there is Bullish outlook on Mindray's entry enabling the company's continuous research and development and sales at home and abroad. The proportion of China's atrial fibrillation pulsed electric field ablation Medical Devices in the cardiac electrophysiology devices will also continue to increase.

Gelonghui FinanceDec 17 15:01 · Ratings

APT Medical Gets Registration Certificate for Two Cardiac Devices

MT NewswiresDec 17 13:32

APT Medical Inc. (688617): PFA has obtained NMPA certification, and the product matrix is becoming increasingly rich.

Event: On December 16, 2024, APT Medical Inc. announced that its single-use cardiac pulsed electric field ablation catheter and Shanghai Hongtong cardiac pulsed electric field ablation device obtained Class III NMPA registration certificate for drug treatment.

Guosheng SecuritiesDec 17 12:36